Oppenheimer Asset Management Inc. Jazz Pharmaceuticals PLC Transaction History
Oppenheimer Asset Management Inc.
- $7.78 Billion
- Q1 2025
A detailed history of Oppenheimer Asset Management Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 10,191 shares of JAZZ stock, worth $1.19 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
10,191
Previous 9,588
6.29%
Holding current value
$1.19 Million
Previous $1.18 Million
7.2%
% of portfolio
0.02%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding JAZZ
# of Institutions
587Shares Held
60.1MCall Options Held
424KPut Options Held
190K-
Black Rock Inc. New York, NY6.15MShares$717 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.02MShares$702 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.47MShares$288 Million0.73% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.33MShares$271 Million0.07% of portfolio
-
State Street Corp Boston, MA1.97MShares$229 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.31B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...